Albert Castro
About Albert Castro
Albert Castro is a Cell Therapy Specialist III and Manufacturing Lead at Kite Pharma, Inc., where he has worked since 2021. He has previous experience as a Laboratory Specialist Lead at Hemacare Corporation and as a Manufacturing Associate II at Baxter International Inc.
Work at Kite Pharma
Albert Castro has been employed at Kite Pharma, Inc. since 2020. He currently holds the position of Cell Therapy Specialist III, Manufacturing Lead, a role he has occupied since 2021. His responsibilities include overseeing manufacturing processes related to cell therapy, ensuring compliance with industry standards, and leading a team in El Segundo, California. His tenure at Kite Pharma has contributed to advancements in cell therapy production.
Previous Experience in Cell Therapy and Manufacturing
Before joining Kite Pharma, Albert Castro worked at Hemacare Corporation as a Laboratory Specialist Lead for six months in 2009. He also served as a Manufacturing Associate II at Baxter International Inc. from 2008 to 2009, where he gained valuable experience in manufacturing processes. His background in these roles has equipped him with a solid foundation in laboratory and manufacturing operations.
Education and Expertise
Albert Castro studied at California State University-Los Angeles. His educational background has provided him with the knowledge and skills necessary for his career in cell therapy and manufacturing. His expertise in these areas is reflected in his current role at Kite Pharma, where he applies his academic training to practical applications in the field.
Career Timeline
Albert Castro's career in the biotechnology and manufacturing sectors spans several years. He began his professional journey at Baxter International Inc. in 2008, followed by a position at Hemacare Corporation in 2009. In 2020, he joined Kite Pharma, where he has progressed to the role of Cell Therapy Specialist III, Manufacturing Lead. This timeline illustrates his growth and commitment to the field of cell therapy.